Phase II Study Evaluating the Efficacy and Safety of KX-826

Clinical trial NCT05940506 · COMPLETED

Trial details

NCT number: NCT05940506
Sponsor: Suzhou Kintor Pharmaceutical Inc,
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Androgenetic Alopecia (AGA)

Start date: 2020-09-28
Primary completion: 2021-07-08
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.